Key Takeaways
- • Liberty Mutual Insurance elected Scott M. Sperling, Co-Chief Executive Officer of Thomas H. Lee Partners, to its board of directors on September 10, 2026, adding four decades of private equity and institutional finance expertise to the insurer's governance.
- • Sperling has been with Thomas H. Lee Partners since 1994 and has helped grow the Boston-based firm to manage more than $50 billion in equity capital across partnerships with more than 175 companies, positioning him as a seasoned capital allocator and portfolio strategist.
- • Prior to Thomas H. Lee Partners, Sperling spent more than a decade as managing partner of Harvard Management Company's alternative asset management affiliate, overseeing Harvard University's endowment fund's non-traditional investments, and earlier served as senior consultant at Boston Consulting Group.
- • Sperling brings substantial board experience, including service on Thermo Fisher Scientific's board since 2006 and as its lead director since 2022, demonstrating established expertise in guiding complex organizations and institutional governance.
- • Liberty Mutual Chairman, President and CEO Tim Sweeney emphasized that Sperling's perspective on capital allocation, long-term value creation, and complex organizational leadership will strengthen the insurer's business strategy and customer delivery capabilities.
Summary
Liberty Mutual Insurance appointed Scott M. Sperling to its board of directors, effective September 10, 2026, leveraging his extensive background in private equity and institutional capital management. Sperling serves as Co-Chief Executive Officer of Thomas H. Lee Partners, one of the most prominent middle-market private equity firms globally, where he has held leadership positions since 1994.
As co-CEO and co-chair of Thomas H. Lee Partners' management committee, Sperling has played a critical role in shaping the firm's investment strategy and portfolio oversight across decades of operational growth. Under his stewardship, Thomas H. Lee Partners expanded to manage more than $50 billion in equity capital and maintain active partnerships with more than 175 portfolio companies across diverse industries. This scale and diversification experience positions Sperling to contribute meaningful perspectives on institutional portfolio management and capital deployment—areas highly relevant to a major insurance company's asset management and strategic planning.
Sperling's career trajectory reflects sustained success across multiple institutional environments. Before joining Thomas H. Lee Partners, he spent more than a decade as managing partner of the Harvard Management Company affiliate responsible for alternative asset classes within Harvard University's endowment fund, a role that required sophisticated evaluation of complex investment opportunities and risk management across non-traditional asset categories. His earlier experience included senior positions at Boston Consulting Group, providing strategic advisory expertise.
His board experience extends to the public markets through his decade-long service on Thermo Fisher Scientific's board, where he assumed the role of lead director in 2022. Liberty Mutual CEO Tim Sweeney noted that Sperling's experience "guiding complex organizations as a director and board chair" combined with his "perspective on capital allocation and long-term value creation" would be "invaluable" to Liberty Mutual's strategic direction. This appointment signals Liberty Mutual's intent to strengthen its governance and strategic advisory capacity with institutional-grade private equity expertise.
As co-CEO and co-chair of Thomas H. Lee Partners' management committee, Sperling has played a critical role in shaping the firm's investment strategy and portfolio oversight across decades of operational growth. Under his stewardship, Thomas H. Lee Partners expanded to manage more than $50 billion in equity capital and maintain active partnerships with more than 175 portfolio companies across diverse industries. This scale and diversification experience positions Sperling to contribute meaningful perspectives on institutional portfolio management and capital deployment—areas highly relevant to a major insurance company's asset management and strategic planning.
Sperling's career trajectory reflects sustained success across multiple institutional environments. Before joining Thomas H. Lee Partners, he spent more than a decade as managing partner of the Harvard Management Company affiliate responsible for alternative asset classes within Harvard University's endowment fund, a role that required sophisticated evaluation of complex investment opportunities and risk management across non-traditional asset categories. His earlier experience included senior positions at Boston Consulting Group, providing strategic advisory expertise.
His board experience extends to the public markets through his decade-long service on Thermo Fisher Scientific's board, where he assumed the role of lead director in 2022. Liberty Mutual CEO Tim Sweeney noted that Sperling's experience "guiding complex organizations as a director and board chair" combined with his "perspective on capital allocation and long-term value creation" would be "invaluable" to Liberty Mutual's strategic direction. This appointment signals Liberty Mutual's intent to strengthen its governance and strategic advisory capacity with institutional-grade private equity expertise.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.